-
Abbott, MSD partner to distribute oral anti-diabetic portfolio in India
19 Jun 2025 12:22 GMT
… developed by MSD Pharmaceuticals
Multinational healthcare companies … treatment of Type 2 diabetes are marketed under the brand names Januvia, Janumet … and a complete diabetes medicines portfolio. Through our … trust of both doctors and patients.”
Comments …
-
Abbott & MSD ink strategic pact to distribute innovative oral anti-diabetic medicines in India
19 Jun 2025 08:13 GMT
… MSD’s oral anti-diabetic medicine, sitagliptin, its combination, … the brand names Januvia, Janumet and Janumet XR.
Sitagliptin … treatment of type 2 diabetes. It was discovered and developed by MSD Pharmaceuticals … the trust of both doctors and patients. Our …
-
Abbott, MSD Pharmaceuticals ink distribution pact for oral anti-diabetic medicines in India
18 Jun 2025 13:10 GMT
… brand names Januvia, Janumet and Janumet XR.
Abbott will … the trust of both doctors and patients.
… nutrition and a complete diabetes medicines portfolio. Through our … treatment of Type 2 diabetes. It was discovered and developed by MSD Pharmaceuticals …
-
Abbott to distribute MSD’s diabetes drug in India
18 Jun 2025 16:36 GMT
… for MSD’s oral anti-diabetic medicine sitagliptin, its combination sitagliptin… marketed under brand names Januvia, Janumet and Janumet XR, the companies said … treatment of Type 2 diabetes. It was discovered and developed by MSD Pharmaceuticals …
-
Abbott and MSD Announce Strategic Partnership to Distribute Innovative Oral Anti-Diabetic Medicines in India
18 Jun 2025 17:35 GMT
… brand names Januvia, Janumet and Janumet XR.
Sitagliptin is … treatment of Type 2 diabetes. It was discovered and developed by MSD Pharmaceuticals … nutrition and a complete diabetes medicines portfolio. Through our … the trust of both doctors and patients. Our …
-
Latest News | Abbott, MSD Pharmaceuticals Ink Distribution Pact for Oral Anti-diabetic Medicines in India
18 Jun 2025 12:07 GMT
… brand names Januvia, Janumet and Janumet XR.
Abbott will … the trust of both doctors and patients.
… nutrition and a complete diabetes medicines portfolio. Through our … treatment of Type 2 diabetes. It was discovered and developed by MSD Pharmaceuticals …
-
Health Care Week in Review: HHS Releases Notice of Benefit and Payment Parameters for 2026 and CMS Identifies Drugs for Second Round of Medicare Price Negotiations
21 Jan 2025 03:58 GMT
… evidence available for specific medical treatments and technologies through a … the National Institute of Diabetes and Digestive and … its confirmatory trial delayed. OIG recommended FDA define specific …
JANUMET; JANUMET XR
Otezla
On January 15, 2025, the Drug …
-
Ozempic, Wegovy Among 15 Drugs Selected by HHS for Medicare Price Negotiations
17 Jan 2025 20:06 GMT
… next 15 drugs to undergo Medicare drug price negotiations with pharmaceutical companies, as … life-saving treatments at lower costs.”
The drugs up for … depressive disorder, and schizophrenia.
Janumet, Janumet XR: Diabetes drugs.
Otezla: Used for oral …
-
Chong Kun Dang wins Korean nod for diabetes combo as rivals crowd in
10 Apr 2025 09:05 GMT
… 24-week, placebo-controlled trial, the 10 mg empagliflozin … adverse events across treatment arms. No serious drug-related events were … Korea’s fast-growing diabetes market. The company has … and distribute Januvia, Janumet, and Janumet XR through 2038.
-
CMS doubles down on Medicare drug price negotiations
17 Mar 2025 13:46 GMT
… , Breo Ellipta, Tradjenta, Xifaxan, Vraylar, Janumet, and Otezla to be included … negotiations aimed at reducing drug costs for Medicare beneficiaries.
On March 14 … about 14% of Medicare Part D's prescription drug costs, according …